These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 27135408)

  • 1. Medium Renewal Blocks Anti-Proliferative Effects of Metformin in Cultured MDA-MB-231 Breast Cancer Cells.
    Rajh M; Dolinar K; Miš K; Pavlin M; Pirkmajer S
    PLoS One; 2016; 11(5):e0154747. PubMed ID: 27135408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The anti-proliferative effect of metformin in triple-negative MDA-MB-231 breast cancer cells is highly dependent on glucose concentration: implications for cancer therapy and prevention.
    Zordoky BN; Bark D; Soltys CL; Sung MM; Dyck JR
    Biochim Biophys Acta; 2014 Jun; 1840(6):1943-57. PubMed ID: 24462945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined treatment with Metformin and 2-deoxy glucose induces detachment of viable MDA-MB-231 breast cancer cells in vitro.
    Bizjak M; Malavašič P; Dolinar K; Pohar J; Pirkmajer S; Pavlin M
    Sci Rep; 2017 May; 7(1):1761. PubMed ID: 28496098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-treatment of breast cancer cells with pharmacologic doses of 2-deoxy-D-glucose and metformin: Starving tumors.
    Wokoun U; Hellriegel M; Emons G; Gründker C
    Oncol Rep; 2017 Apr; 37(4):2418-2424. PubMed ID: 28350075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of metformin on estrogen and progesterone receptor-positive (MCF-7) and triple-negative (MDA-MB-231) breast cancer cells.
    Amaral I; Silva C; Correia-Branco A; Martel F
    Biomed Pharmacother; 2018 Jun; 102():94-101. PubMed ID: 29550639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High Glucose Represses the Anti-Proliferative and Pro-Apoptotic Effect of Metformin in Triple Negative Breast Cancer Cells.
    Varghese S; Samuel SM; Varghese E; Kubatka P; Büsselberg D
    Biomolecules; 2019 Jan; 9(1):. PubMed ID: 30626087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Triple Combination of Metformin, Acetylsalicylic Acid, and Oseltamivir Phosphate Impacts Tumour Spheroid Viability and Upends Chemoresistance in Triple-Negative Breast Cancer.
    Sambi M; Samuel V; Qorri B; Haq S; Burov SV; Markvicheva E; Harless W; Szewczuk MR
    Drug Des Devel Ther; 2020; 14():1995-2019. PubMed ID: 32546966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-tumor effects of everolimus and metformin are complementary and glucose-dependent in breast cancer cells.
    Ariaans G; Jalving M; Vries EG; Jong S
    BMC Cancer; 2017 Mar; 17(1):232. PubMed ID: 28356082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Combination Therapy with Chemical Drugs and Megavoltage X-ray Exposure on Breast Cancer Stem Cells' Viability and Proliferation of MCF-7 and MDA-MB-231 Cell Lines.
    Banisharif Dehkordi F; Ghatrehsamani M; Abdolvand M; Soltani A; Masoumi SH
    Curr Pharm Des; 2024; 30(17):1341-1353. PubMed ID: 38676476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in [18F]Fluoro-2-deoxy-D-glucose incorporation induced by doxorubicin and anti-HER antibodies by breast cancer cells modulated by co-treatment with metformin and its effects on intracellular signalling.
    Cooper AC; Fleming IN; Phyu SM; Smith TA
    J Cancer Res Clin Oncol; 2015 Sep; 141(9):1523-32. PubMed ID: 25579456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin inhibits human breast cancer cell growth by promoting apoptosis via a ROS-independent pathway involving mitochondrial dysfunction: pivotal role of superoxide dismutase (SOD).
    Sharma P; Kumar S
    Cell Oncol (Dordr); 2018 Dec; 41(6):637-650. PubMed ID: 30088260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microarray analysis of breast cancer gene expression profiling in response to 2-deoxyglucose, metformin, and glucose starvation.
    Aoun R; El Hadi C; Tahtouh R; El Habre R; Hilal G
    Cancer Cell Int; 2022 Mar; 22(1):123. PubMed ID: 35305635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin Induces Apoptosis and Downregulates Pyruvate Kinase M2 in Breast Cancer Cells Only When Grown in Nutrient-Poor Conditions.
    Silvestri A; Palumbo F; Rasi I; Posca D; Pavlidou T; Paoluzi S; Castagnoli L; Cesareni G
    PLoS One; 2015; 10(8):e0136250. PubMed ID: 26291325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Citral induced apoptosis in MDA-MB-231 spheroid cells.
    Nigjeh SE; Yeap SK; Nordin N; Kamalideghan B; Ky H; Rosli R
    BMC Complement Altern Med; 2018 Feb; 18(1):56. PubMed ID: 29433490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose-deprivation increases thyroid cancer cells sensitivity to metformin.
    Bikas A; Jensen K; Patel A; Costello J; McDaniel D; Klubo-Gwiezdzinska J; Larin O; Hoperia V; Burman KD; Boyle L; Wartofsky L; Vasko V
    Endocr Relat Cancer; 2015 Dec; 22(6):919-32. PubMed ID: 26362676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of the targeting properties of 2-deoxy-D-glucose-conjugated nanoparticles to breast cancer MDA-MB-231 cells and breast fibroblasts cells].
    Wang P; Shan XH; Xiong F; Gu N; Qian H; Fan Y; Wang YF
    Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):566-71. PubMed ID: 24314212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein N-glycosylation alteration and glycolysis inhibition both contribute to the antiproliferative action of 2-deoxyglucose in breast cancer cells.
    Berthe A; Zaffino M; Muller C; Foulquier F; Houdou M; Schulz C; Bost F; De Fay E; Mazerbourg S; Flament S
    Breast Cancer Res Treat; 2018 Oct; 171(3):581-591. PubMed ID: 29971627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do MCF7 cells cope with metformin treatment under energetic stress in low glucose conditions?
    Dogan Turacli I; Umudum H; Pampal A; Candar T; Kavasoglu L; Sari Y
    Mol Biol Rep; 2018 Jun; 45(3):195-201. PubMed ID: 29397517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose promotes breast cancer aggression and reduces metformin efficacy.
    Wahdan-Alaswad R; Fan Z; Edgerton SM; Liu B; Deng XS; Arnadottir SS; Richer JK; Anderson SM; Thor AD
    Cell Cycle; 2013 Dec; 12(24):3759-69. PubMed ID: 24107633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anti-diabetic drug metformin suppresses self-renewal and proliferation of trastuzumab-resistant tumor-initiating breast cancer stem cells.
    Vazquez-Martin A; Oliveras-Ferraros C; Del Barco S; Martin-Castillo B; Menendez JA
    Breast Cancer Res Treat; 2011 Apr; 126(2):355-64. PubMed ID: 20458531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.